GEOVAX LABS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GEOVAX LABS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $3.55M.
- GEOVAX LABS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $1.72M, a 78.28% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $7.97M, a 48.64% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $7.91M.
- GEOVAX LABS, INC. stock issued during period, value, new issues for fiscal 2022 was $27.73M, a 194.69% increase from fiscal 2021.
- GEOVAX LABS, INC. stock issued during period, value, new issues for fiscal 2021 was $9.41M, a 15.68% decline from fiscal 2020.
- GEOVAX LABS, INC. stock issued during period, value, new issues for fiscal 2020 was $11.16M.
- GEOVAX LABS, INC. stock issued during period, value, new issues for fiscal 2012 was $273.36K, a 38.04% decline from fiscal 2011.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $3.55M S-1 · filed 2026-09-17 | |
| 2026-03-31 | $1.72M S-1 · filed 2026-09-17 | |
| 2025-12-31 | $18.92M S-1 · filed 2026-09-17 | |
| 2025-09-30 | $7.97M 10-Q · filed 2025-11-13 | |
| 2025-03-31 | $7.91M S-1 · filed 2026-09-17 | |
| 2024-12-31 | $21.40M S-1 · filed 2026-09-17 | |
| 2024-09-30 | $15.52M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.21M 10-Q · filed 2025-11-13 | |
| 2022-12-31 | $27.73M 10-K · filed 2024-02-29 | |
| 2022-06-30 | $18.50M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $9.23M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $9.41M 10-K · filed 2023-03-23 | |
| 2021-03-31 | $9.41M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $11.16M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $11.16M 10-Q · filed 2021-11-12 | |
| 2012-12-31 | $273.36K 10-K · filed 2015-03-20 | |
| 2011-12-31 | $441.21K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $90.00K 10-K · filed 2014-03-14 | |
| 2009-12-31 | $1.52M 10-K · filed 2014-03-14 | |
| 2008-12-31 | $1.77M 10-K · filed 2014-03-14 | |
| 2007-12-31 | $3.16M 10-K · filed 2014-03-14 | |
| 2004-12-31 | $239.92K 10-K · filed 2014-03-14 | |
| 2003-12-31 | $2.46M 10-K · filed 2014-03-14 | |
| 2002-12-31 | $470.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |